The Faces of Luminex: Eva Oleksy, Clinical Research

Luminex develops a number of instruments and molecular diagnostic tests that have to be reviewed by regulatory agencies before becoming commercially available. Each of them requires clinical trials to demonstrate accuracy and utility. For this, we count on team members like Eva Oleksy, Senior Clinical Research Associate. She joined Luminex in 2009, and holds a […]

Read More…

The Versatility of Multiplex Antibody Titer Assays for COVID-19 and Beyond

  The COVID-19 outbreak that began in Wuhan, China in December 2019 was marked by an increase in the number of cases showing pneumonia-like symptoms.1,2 It was not until about a month after the outbreak began that genomic analysis identified a novel coronavirus as the causative agent. With the emergence of new pathogen strains, genomic […]

Read More…

xMAP® Connect Virtual Conference – Inspiring Multiplexing Innovation

Luminex is proud to announce the xMAP® Connect Virtual Conference, hosted online this year by LabRoots. The goal of this conference is to connect fellow xMAP enthusiasts and provide best practices for multiplex assays, virtually from anywhere in the world. Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single […]

Read More…

In Germany, Screening for COVID-19 with the ARIES® System

Clinical lab scientist describes his experience establishing a two-step diagnostic algorithm for COVID-19 Scientists in clinical labs worldwide have worked night and day in the COVID-19 pandemic to develop, validate, and implement new diagnostic tests for patients believed to be infected by the SARS-CoV-2 virus. While each lab’s experiences are slightly different, there are certain […]

Read More…

Luminex’s Flexible SARS-CoV-2 Assays Enable Both High-Throughput and Emergency Testing

Federal funding and FDA Emergency Use Authorization streamlined development and commercialization of these new assays. As the COVID-19 pandemic swept across the globe, people everywhere have raced to respond. The Luminex team has been working around the clock on much-needed molecular diagnostic assays for the SARS-CoV-2 virus, two of which recently received Emergency Use Authorization […]

Read More…

Questions to Ask When Choosing a Multiplex Assay Kit

  With the COVID-19 pandemic in full swing, many researchers are looking to multiplex assays to evaluate what they call the “cytokine storm.” This refers to the increase in pro-inflammatory cytokines like IL-6 in patients with COVID-19, which is believed to predict disease severity.1 Many of Luminex’s Partners already have multiplex assays available for research […]

Read More…

How Luminex Is Supporting Research Partners’ Pandemic Response

Licensed Technologies Group is finding new ways to boost partner programs Here at Luminex, we are working on all fronts to help fight the coronavirus pandemic. The most visible activities have been the launch of new diagnostic tests—namely, the NxTAG® CoV Extended Panel and the ARIES® SARS-CoV-2 Assay—both of which received Emergency Use Authorization from […]

Read More…

Considerations Regarding RNA Extraction Kits for SARS-CoV-2 Detection

The novel coronavirus disease (COVID-19) pandemic continues to trigger rapid development of molecular diagnostic tests around the world. Nucleic acid amplification-based tests (NAATs)—such as real-time PCR and isothermal amplification—are the gold standard in molecular diagnostic technologies that are being utilized to detect SARS-CoV-2, the COVID-19 disease-causing virus.1 There are two critical and sequential steps that […]

Read More…

Webinar: Mouse Model Analysis Is Better with Multiplexing

Query hundreds of immunoassay targets, even with limited sample volume To make the most of immunology-focused assays using the limited tissue and fluid samples available from mouse models, scientists should consider using xMAP® Technology from Luminex, according to Daniel Braunschweig, Proteomics Field Application Scientist Leader at Bio-Rad Laboratories. That’s the takeaway from a 30-minute webinar […]

Read More…

How to Choose an Assay Development Platform

The Luminex Team knows assay development. Check out some tips from our experts below. If you need to design a new assay, there are several factors you’ll want to consider before selecting the platform you’ll develop it on. Based on our experience, these are the most important: Analyte of interest: Is your assay meant to […]

Read More…